Phase 1 Adult T-cell Leukemia/Lymphoma Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma

Adult T-Cell Leukemia/Lymphoma (ATLL)

Otsuka Medical Devices Co., Ltd. Japan49 enrolled5 locationsNCT07075328

Recruiting

Phase 1

Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

Recurrent Adult T-Cell Leukemia/LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaRefractory Adult T-Cell Leukemia/Lymphoma+1 more

John Reneau12 enrolled1 locationNCT04848064